Physician profile
Triz V Smith
NPI 1962585448
$5,120.51
in general payments reported to CMS, 2019-2025
29 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2021: $441 · 2022: $3,031 · 2023: $390 · 2024: $430 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,472.35 | 2021-2024 | |
| Astellas Pharma US INC | $187.58 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $166.10 | 2023-2024 | Myfembree, Gemtesa |
| Abbvie INC. | $163.47 | 2019 | |
| Sage Therapeutics, LLC | $161.68 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $100.76 | 2023-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Hologic Sales and Service, LLC | $89.06 | 2023-2025 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $86.47 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $62.14 | 2019 | |
| Exact Sciences Corporation | $61.80 | 2023 | Cologuard Collection Kit |
| Optumhealth Care Solutions, LLC | $56.53 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Shield Therapeutics INC | $52.92 | 2023-2025 | Accrufer |
| Kerecis Limited | $45.30 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Duchesnay USA Incorporated | $43.20 | 2019 | |
| Supernus Pharmaceuticals, INC. | $40.01 | 2025 | Qelbree |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $37.80 | 2024-2025 | Pico 14, Pico |
| Daiichi Sankyo INC. | $36.61 | 2019 | |
| Pfizer INC. | $32.73 | 2019-2025 | |
| Exeltis, USA INC. | $28.28 | 2024 | Slynd |
| Novo Nordisk INC | $24.68 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.98 | 2019 | |
| Hydrofera LLC | $22.67 | 2025 | Leukomed Sorbact |
| Convatec INC. | $22.39 | 2024 | |
| Medtronic, INC. | $22.23 | 2024 | Ligasure |
| Minerva Surgical, INC | $21.63 | 2025 | |
| Organon LLC | $16.45 | 2024 | |
| Mallinckrodt Enterprises LLC | $15.75 | 2019 | |
| Agile Therapeutics, INC. | $14.13 | 2021 | |
| Aspira Women'S Health INC | $12.81 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Triz Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.